- Novel Coronavirus
-
Drug Discovery Services
- Antiviral Drug Discovery
- Complement Therapy
- SARS-CoV-2 Aptamers
- Antisense Oligonucleotides
- Protease Inhibitors
- Inhibitor of Host Cell Protease
- Abelson Kinase Inhibitors
- RNA Synthesis Inhibitors
- Nucleoside Analogue
- Neuraminidase Inhibitors
- Neutralizing Antibody
- Antiviral Peptide
- Broad-spectrum Antiviral Drug
- Anti-Inflammatory Drugs
- High-Throughput Screening
- Vaccine Discovery
- Evaluation Platforms for SARS-CoV-2 Drugs
- Antiviral Drug Discovery
- IVD Immunoassays
- Products
- Resources
- About Us
Detection Kit
The detection of SARS-CoV-2 (2019-nCoV) can be performed at both the nucleic acid and protein levels. Based on its deep background in genetics and immunology, Creative Biolabs has developed a series of detection kits for SARS-CoV-2 related proteins, antibodies, and nucleic acids. The SARS-CoV-2 detection kits are based on the principles of ELISA, immuno-chromatography, and RT-PCR, which makes them able to qualitatively or quantitatively detect the level of anti-SARS-CoV-2 IgG / IgM antibody as well as SARS-CoV-2 nucleic acid content, respectively. The detection of SARS-CoV-2 nucleic acids, proteins, and antibodies can help accelerate the development of related mechanisms, drugs, and vaccines. Our products have sufficient stocks, welcome to inquire.